WRBY
Warby Parker Inc.Price & Indicators
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Active Customers | 2.69M | trailing 12-month basis | — |
| Average Revenue per Customer | $331 | first quarter ended March 31, 2026 | — |
| Net new stores opened | 14 | first quarter ended March 31, 2026 | — |
| Total stores | 337 | Q1 2026 | — |
| adjusted EBITDA non-GAAP | $30M | Q1 FY2026 call | — |
| adjusted EBITDA margin non-GAAP | 12.2% | Q1 FY2026 call | — |
| e-commerce revenue growth | -4% | Q1 FY2026 call | — |
| exams year-over-year growth | 30% | Q1 FY2026 call | — |
| Stores | 323 | full year 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
WRBY
this stock
Warby Parker Inc.
|
$3.39B | +26.6% | +13.0% | 2759.0 | 14.4% |
|
ISRG
Intuitive Surgical Inc
|
$142.49B | -31.3% | +20.5% | 48.9 | 2.1% |
|
MDLN
Medline Inc.
|
$54.01B | -2.1% | +11.5% | — | 2.8% |
|
BDX
Becton Dickinson & Co
|
$44.07B | +2.9% | +8.2% | 60.8 | 4.1% |
|
ALC
Alcon Inc
|
$34.44B | -10.4% | +10.5% | — | 2.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| WRBY | -5.9% | +9.8% | +3.1% | -9.1% | +26.6% |
| SPY | -0.1% | +0.1% | +9.0% | +0.5% | +10.1% |
| vs SPY | -5.8% | +9.7% | -5.8% | -9.6% | +16.5% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.